Sanofi announces changes to its Executive Committee
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc
He has over two decades of leadership experience as an innovative strategic planner in finance diligence
The committee voted that FDA should restrict use of LYNPARZA plus abi/pred to these BRCAm mCRPC patients
The appointment is effective from May 01, 2023 for five years
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
Subscribe To Our Newsletter & Stay Updated